8 days ago
PVLA
AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 19%
#953 out of 5208 analysts
Average Return
+13.49%
Win Rate
59%19 out of 32
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Perspective Therapeutics IncCATX | +105.98% | $2.51 | $5.17 | 2026-01-12 - 2026-03-03 | Strong Buy |
Kymera Therapeutics IncKYMR | +92.85% | $45.05 | $86.88 | 2024-12-09 - 2025-12-09 | Strong Buy |
Arvinas IncARVN | +73.06% | $7.72 | $13.36 | 2025-09-17 - 2026-03-03 | Strong Buy |
Palvella Therapeutics IncPVLA | +60.57% | $81.90 | $131.51 | 2026-01-28 - 2026-03-03 | Strong Buy |
Kymera Therapeutics IncKYMR | +54.75% | $55.80 | $86.35 | 2025-10-21 - 2026-03-03 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
3 months ago
NRIX
3 months ago
KYMR
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | 3 | Strong Buy | $9.00 | +83.67% | Maintains | 2 days ago |
Kymera Therapeutics IncKYMR | 6 | Strong Buy | $134.00 | +55.18% | Maintains | 6 days ago |
Palvella Therapeutics IncPVLA | 5 | Strong Buy | $215.00 | +63.49% | Maintains | 8 days ago |
Monopar TherapeuticsMNPR | 6 | Strong Buy | $104.00 | +100.46% | Reiterates | 9 days ago |
Nurix Therapeutics IncNRIX | 5 | Strong Buy | $30.00 | +89.75% | Reiterates | a month ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $14.00 | +170.79% | Reiterates | 2 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $28.00 | +56.25% | Initiates Coverage On | 2 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $11.00 | +99.28% | Initiates Coverage On | 3 months ago |
Arvinas IncARVN | 2 | Strong Buy | $14.00 | +4.79% | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.